Uzbekistan discusses the introduction of artificial intelligence in pharmaceuticals
Uzbekistan and Partex AI discussed artificial intelligence, digital technologies, and innovative projects in pharmaceuticals and biomedicine.
Uzbekistan considered the issue of introducing artificial intelligence into the pharmaceutical sector.
The Agency for the Development of Medicine and Pharmaceutical Industry of Uzbekistan discussed the possibilities of using artificial intelligence and digital technologies in the pharmaceutical and biomedical sectors with Partex AI. The meeting was held on August 26, 2026.
During the negotiations, the parties discussed the issues of digitizing the pharmaceutical industry, the effective use of artificial intelligence technologies, and improving the processes of creating medicines. Particular attention was paid to the implementation of modern digital solutions in practice.
The participants of the meeting exchanged views on using the potential of artificial intelligence in the pharmaceutical and biotechnology sectors. The areas discussed included the development of scientific and research activities, improving data analysis, and introducing innovative technologies into production processes.
Representatives of the agency provided information on the existing opportunities for using digital technologies and solutions based on artificial intelligence in the pharmaceutical industry of Uzbekistan. Information was also provided on innovative projects being implemented in the field. At the end of the meeting, the parties agreed to continue the dialogue on the introduction of artificial intelligence and advanced digital technologies in the pharmaceutical sector. In addition, it is planned to develop the exchange of experience and develop promising joint projects.